Biotech Behind Covid Vaccine Valued at $579 Million Before Market Debut Today

Retrieved on: 2021-04-30 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Biotech Behind Covid Vaccine Valued at $579 Million Before Market Debut Today. View article details on hiswai:

Excerpt

The company co-invented a COVID-19 vaccine candidate, AZD1222, with the University of Oxford, which was licensed to AstraZeneca. AstraZeneca has ...

Article found on: www.barrons.com